Close

Stemline Therapeutics (STML) Announces Presentation of SL-701 Phase 2 Data in 2nd-Line GBM

Go back to Stemline Therapeutics (STML) Announces Presentation of SL-701 Phase 2 Data in 2nd-Line GBM